NCT06255132

Brief Summary

The rate of postoperative delirium in patients who underwent cardiac surgery is very high. Different predictors and/or scores were studied for the prediction of Post Operative Delirium (POD)after heart surgery, but none of them was validated. The investigators aim to explore the role of pupillary alterations during anesthesia in open-heart surgery. The goal of this prospective study is to evaluate if pupil alterations during cardiac surgery, evaluated by an automated pupillometer (NPi-200) ( AP), could predict postoperative delirium.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

February 13, 2024

Status Verified

January 1, 2024

Enrollment Period

1.5 years

First QC Date

October 26, 2023

Last Update Submit

February 2, 2024

Conditions

Keywords

automated pupillometrycardiac surgical procedures

Outcome Measures

Primary Outcomes (1)

  • Correlation between neurological pupil index (NPi) and Post-operative delirium

    We want to relate pupillary reactivity, assessed with automated pupillometry such as the Neurological pupil index (numerical value:0-5) during surgery, with Postoperative delirium (assessed with CAM-ICU score during the first 5 postoperative days).

    Intraoperative (day 0)

Secondary Outcomes (4)

  • Correlation between early prediction model for delirium (E-PRE-DELIRIC) and POD

    E-PREDELIRIC is calculated at ICU admission ( day 0)

  • Correlation between regional cerebral saturation (rSO2) and POD occurrence

    rSO2 is monitored during surgery (Day 0)

  • Correlation between Cardiopulmonary bypass duration and POD.

    Intraoperative

  • Multivariate model for POD prediction.

    Day 0

Study Arms (1)

Patients undergoing open heart surgery

EXPERIMENTAL
Device: Automated pupillometer NPi-200

Interventions

Pupillary variables in both eyes are recorded and measured with NPi-200 every 30 minutes from the induction of anesthesia. At the end of the surgery, the patient is transferred to the intensive care unit (ICU), and the pupillary variables are recorded until the patient regains consciousness (Richmond agitation sedation scale, RASS\>-3). Specific hemodynamic, respiratory, surgical, and EBP data are also recorded as well as NIRS variables. As soon as the patient had regained consciousness (RASS \> 3), they were assessed for delirium for a total period of five days. Nursing and/or medical staff administered the CAM-ICU score to patients twice a day (morning and afternoon).

Patients undergoing open heart surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients undergoing elective open cardiac surgery (\>18 yr)
  • Elective open cardiac surgery and cardiopulmonary bypass

You may not qualify if:

  • Patients \<18 years of age
  • Emergency surgeries
  • Heart operations, not including extracorporeal circulation
  • Surgery for aortic arch dissection with hypothermia and/or circulatory arrest
  • Patients affected by psychiatric disorders undergoing with or without neuroleptic therapy
  • Patients who have the refused consent
  • Patients with ocular problems (acute or previous trauma to one or both eyes, blindness, ocular prosthesis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit of Cardiothoracic Anesthesia and Intensive Care, University hospital of Verona

Verona, Vr, 37126, Italy

RECRUITING

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Leonardo Gottin, Prof.

    Universita di Verona

    STUDY DIRECTOR
  • Federico Romagnosi, MD

    Universita di Verona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federico Romagnosi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2023

First Posted

February 13, 2024

Study Start

March 9, 2023

Primary Completion

September 1, 2024

Study Completion

March 1, 2025

Last Updated

February 13, 2024

Record last verified: 2024-01

Locations